AngioDynamics (ANGO) Reports In-Line Q4 EPS, Offers FY20 Guidance

July 10, 2019 7:01 AM

AngioDynamics (NASDAQ: ANGO) reported Q4 EPS of $0.25, in-line with the analyst estimate ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found